Imatinib mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue

Urology

Volumn 78, Issue 4, 2011, Pages 968.e1-968.e6

  Ozgur Akdemir, Alp ^a   Demirturk, Kursat ^b   Karabakan, Mehmet ^a   Volkan Oztekin, Cetin ^a   Abdulkadir, Nour A ^b   Cetinkaya, Mesut ^a   Gur, Serap ^b,c   Hellstrom, Wayne J G ^c  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1H [1,2,4] OXADIAZOLO[4.3 A]QUINOXALIN 1 ONE; ADENOSINE TRIPHOSPHATASE (POTASSIUM); ALFUZOSIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; IMATINIB; N(G) NITROARGININE METHYL ESTER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; DETRUSOR MUSCLE; ELECTROSTIMULATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MUSCLE ISOMETRIC CONTRACTION; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; TRANSURETHRAL RESECTION;

EID: 80053910859     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.06.033     Document Type: Article

References (27)

1. C.G. Chute, L.A. Panser, and C.J. Girman The prevalence of prostatism: a population-based survey of urinary symptoms J Urol 150 1993 85 89
2. A.V. Sarma, S.J. Jacobsen, and C.J. Girman Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men J Urol 168 2002 1446 1452
3. A. Tubaro, S. Carter, and A. Trucchi Early treatment of benign prostatic hyperplasia: implications for reducing the risk of permanent bladder damage Drugs Aging 20 2003 185 195
4. S. Gur, P.J. Kadowitz, and W.J. Hellstrom Guide to drug therapy for lower urinary tract symptoms in patients with benign prostatic obstruction: implications for sexual dysfunction Drugs 68 2008 209 229
5. S. Gur, S.C. Sikka, and S. Chandra Alfuzosin attenuates erectile dysfunction in rats with partial bladder outlet obstruction BJU Int 102 2008 1651 1657
6. S. Furuya, Y. Kumamoto, and E. Yokoyama Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy J Urol 128 1982 836 839
7. M. Emberton, N. Zinner, and M.C. Michel Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk BJU Int 100 2007 249 253
8. E. Ranza, A. Bertolotti, and A. Facoetti Influence of imatinib mesylate on radiosensitivity of astrocytoma cells Anticancer Res 29 2009 4575 4578
9. C.F. Waller Imatinib mesylate Recent Results Cancer Res 184 2010 3 20
10. S.M. Biers, J.M. Reynard, and T. Doore The functional effects of a c-kit tyrosine inhibitor on guinea-pig and human detrusor BJU Int 97 2006 612 616
11. Y. Kubota, S.M. Biers, and K. Kohri Effects of imatinib mesylate (Glivec) as a c-kit tyrosine kinase inhibitor in the guinea-pig urinary bladder Neurourol Urodyn 25 2006 205 210
12. L.M. Popescu, C. Vidulescu, and A. Curici Imatinib inhibits spontaneous rhythmic contractions of human uterus and intestine Eur J Pharmacol 546 2006 177 181
13. G. Hutchings, J. Deprest, and B. Nilius The effect of imatinib mesylate on the contractility of isolated rabbit myometrial strips Gynecol Obstet Invest 62 2006 79 83
14. P. Mathew, I.J. Fidler, and C.J. Logothetis Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancer Semin Oncol 31 2004 24 29
15. Y. Xu, F. Fang, and Y. Sun RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells Mol Cancer Ther 9 2010 803 812
16. F.C. Banks, G.E. Knight, and R.C. Calvert Alterations in purinergic and cholinergic components of contractile responses of isolated detrusor contraction in a rat model of partial bladder outlet obstruction BJU Int 97 2006 372 378
17. P. Hedlund Nitric oxide/cGMP-mediated effects in the outflow region of the lower urinary tractis there a basis for pharmacological targeting of cGMP? World J Urol 23 2005 362 367
18. A. Moon Influence of nitric oxide signalling pathways on pre-contracted human detrusor smooth muscle in vitro BJU Int 89 2002 942 949
19. M. Takeda, R. Tang, and E. Shapiro Effects of nitric oxide on human and canine prostates Urology 45 1995 440 446
20. Y. Wada, W. Takahashi, and J. Latifpour Regional differences in the functional and biochemical properties of endothelin receptor subtypes in the rabbit prostatic urethra BJU Int 100 2007 430 437
21. S. Gur, P.J. Kadowitz, and W.J. Hellstrom Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction Curr Pharm Des 16 2010 1619 1633
22. C.M. Liu, Y.C. Lo, and B.N. Wu CGMP-enhancing- and alpha1A/alpha1D- adrenoceptor blockade-derived inhibition of Rho-kinase by KMUP-1 provides optimal prostate relaxation and epithelial cell anti-proliferation efficacy Prostate 67 2007 1397 1410
23. A.L. Cook, M. Frydenberg, and J.M. Haynes Protein kinase G activation of K(ATP) channels in human-cultured prostatic stromal cells Cell Signal 14 2002 1023 1029
24. A.L. Burnett, M.P. Maguire, and S.L. Chamness Characterization and localization of nitric oxide synthase in the human prostate Urology 45 1995 435 439
25. W.A. Lau, S. Ventura, and J.N. Pennefather Pharmacology of neurotransmission to the smooth muscle of the rat and the guinea-pig prostate glands J Auton Pharmacol 18 1998 349 356
26. J.N. Pennefather, W.A. Lau, and F. Mitchelson The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies J Auton Pharmacol 20 2000 193 206
27. S. Oger, D. Behr-Roussel, and D. Gorny Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human detrusor and prostatic tissues in vitro Eur Urol 57 2010 699 707